Jun 18, 2021 / 11:30AM GMT
Operator
Ladies and gentlemen, thank you for standing by. We welcome you to the Jubilant Pharmova Virtual Meet. (Operator Instructions)
I now hand over the proceedings to Mr. Hemant Bakhru, Investor Relations at Jubilant Pharmova. Thank you, and over to you.
Hemant Bakhru - Jubilant Pharmova Limited - Head of IR
Thank you, Adithya. Good evening, everyone. Thank you for joining Jubilant Pharmova's Analyst Meet. I would like to remind you that some of the statements made on the call today could be forward-looking in nature, and a detailed disclaimer in this regard has been included in the presentation.
On the call today, we have Ms. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. Arvind Chokhany, Group CFO; Mr. Pramod Yadav, CEO, Jubilant Pharma; Mr. Sergio Calvo, President, Radiopharmaceuticals; Mr. Chris Preti, President Allergy business unit; Mr. Amit Arora, President, CMO; Mr. Gunjan, Head, API business; Mr. Terry Fullem, President, Jubilant Cadista; and Mr. Jasdeep, President, Generics Non-U.S. business. Finally, Mr
Jubilant Pharmova Ltd Investor & Analyst Meet Transcript
Jun 18, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers